ozempic teeth: dentists warn of new glp-1 side effect and tooth decay: warning for GLP‑1 weight-loss users If you’re taking a GLP-1

MYTH #3: Patients can't afford FDA-approved versions, so we have medical necessity. REALITY: Cost alone is not recognized as a medical necessity under federal compounding laws

Compounded tirzepatide is not FDA-approved

Additionally, GLP-1 may slow stomach emptying and aid in reducing appetite, potentially contributing to weight loss

Virtual GLP-1 startups: Pill mills or the future of obesity care

The composite renal outcome (the first occurrence of new macroalbuminuria, a sustained decline in eGFR of 30% from baseline, or RRT) developed less frequently in participants using dulaglutide in comparison to those using placebo [HR 0.85 (95% CI: 0.770.93), p=0.0004]

In fact, studies have shown that GLP-1 agonists can positively affect cardiovascular health, offering you an additional layer of protection while you shed those excess pounds